Lv3
306 积分 2024-07-18 加入
POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESE SUBJECTS
2个月前
已完结
Novel Aptamer-Drug Conjugate for Targeted Therapy in Triple-Negative Breast Cancer
5个月前
已完结
Subcellular targeting strategies for protein and peptide delivery
8个月前
已完结
Approvals by the China NMPA in 2025
8个月前
已完结
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
10个月前
已完结
Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement
11个月前
已完结
Atherogenesis in transgenic mice expressing human apolipoprotein(a)
11个月前
已完结
Fibrinolysis and tranexamic acid: mechanistic principles
11个月前
已完结
siRNA modification and delivery for drug development
11个月前
已关闭
FB-7011: A Novel, Long-Duration siRNA Dual-Targeting Both Complement Factor B (CFB) and Mannan-Binding Lectin Serine Protease 2 (MASP2) Exhibits Therapeutic Potential for Treatment of IgAN
11个月前
已关闭